PIII — P3 Health Partners Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual income statement for P3 Health Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	486	637	1,049	1,266	1,500
Cost of Revenue
Gross Profit	0.028	-22	-7.75	31.6	-58.9
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	521	825	2,610	1,434	1,821
Operating Profit	-35.1	-188	-1,561	-168	-321
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-45.4	-204	-1,560	-184	-306
Provision for Income Taxes
Net Income After Taxes	-45.4	-204	-1,562	-186	-310
Minority Interest
Net Income Before Extraordinary Items
Net Income	-41.1	-156	-270	-57.8	-136
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-41.1	-156	-270	-57.8	-136
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-49.4	-188	714	-29.5	-49.5